OMX Copenhagen 20 998018
8’832.20
Pkt
-109.10
Pkt
-1.22
%
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Copenhagen 20-Werten
| 02.01.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
| 23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
| 23.12.24 | Novo Nordisk Halten | DZ BANK | |
| 20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 20.12.24 | Novo Nordisk Neutral | UBS AG | |
| 20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.12.24 | Novo Nordisk Neutral | UBS AG | |
| 16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.12.24 | Novo Nordisk Neutral | UBS AG | |
| 09.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 04.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.12.24 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.12.24 | Novo Nordisk Neutral | UBS AG | |
| 01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 18.11.24 | Novo Nordisk Neutral | UBS AG | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 14.11.24 | A.P. Moeller - Maersk A-S Neutral | Goldman Sachs Group Inc. | |
| 13.11.24 | Novo Nordisk Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
| 07.11.24 | Novo Nordisk Neutral | UBS AG | |
| 07.11.24 | Novo Nordisk Halten | DZ BANK | |
| 07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 04.11.24 | Novo Nordisk Neutral | UBS AG |